HUMA THERAPEUTICS LIMITED

Active London
337 employees website.com
Healthcare and wellbeing
H

HUMA THERAPEUTICS LIMITED

Founded 2 Aug 2011 Active London, England 337 employees website.com
Healthcare and wellbeing

Previous Company Names

HUMAFORHEALTH LIMITED 16 Apr 2020 — 17 Apr 2020
MEDOPAD LTD 2 Aug 2011 — 16 Apr 2020
Accounts Submitted 23 Oct 2025 Next due 29 Sept 2026 5 months remaining
Confirmation Submitted 10 Dec 2025 Next due 9 Dec 2026 7 months remaining
Net assets £71M £10M 2024 year on year
Total assets £97M £3M 2024 year on year
Total Liabilities £26M £7M 2024 year on year
Charges 1
1 satisfied

Contact & Details

Contact

Registered Address

13th Floor Millbank Tower 21-24 Millbank London SW1P 4QP England

Telephone

0800 000 0000

Email

info@example.com

Website

www.example.com

Full company profile for HUMA THERAPEUTICS LIMITED (07725451), an active healthcare and wellbeing company based in London, England. Incorporated 2 Aug 2011. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type Total Exemption Full
Next accounts 31 December 2025
Due by 30 September 2026 9 months

Net Assets, Total Assets & Total Liabilities (2019–2024)

Cash in Bank

£11.93M

Increased by £384.00k (+3%)

Net Assets

£71.39M

Decreased by £10.09M (-12%)

Total Liabilities

£25.76M

Increased by £7.05M (+38%)

Turnover

£30.07M

Decreased by £550.00k (-2%)

Employees

337

Decreased by 34 (-9%)

Debt Ratio

27%

Increased by 8 (+42%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
Dec Year End
2023
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

Funding Rounds 6
Grants 1

Investors (12)

Investor NameInvestor SinceParticipating Rounds
Investor 12Nov 2019Series B
Investor 4May 2021Series D, Series C
Investor 5May 2021Series C

Share Capital

Share Capital

Share allotments and capital structure

66 Allotments 13,920,348 Shares £160.07m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
25 Apr 2025613,380£10.71m£17.466
25 Apr 2025129,620£2.26m£17.466
11 Mar 20252,185£40k£18.2
14 Nov 202448,575£4k£0.08
14 Nov 20243,030£3k£0.88

Officers

Officers

1 active 2 resigned
Status
Danoosh VahdatDirectorBritishUnited Kingdom411 Aug 2012Active

Shareholders

Shareholders (160)

Danoosh Vahdat
13.3%
4,500,000
Rich Khatib
11.6%
3,934,926

Persons with Significant Control

Persons with Significant Control (1)

1 Active 2 Ceased

Danoosh Vahdat

British

Active
Notified 9 Apr 2020
Residence United Kingdom
DOB August 1984
Nature of Control
  • Ownership Of Shares 25 To 50 Percent,voting Rights 25 To 50 Percent,right To Appoint And Remove Directors

Danoosh Vahdat

Ceased 17 Jan 2019

Ceased

Rich Khatib

Ceased 17 Jan 2019

Ceased

Group Structure

Group Structure

HUMA THERAPEUTICS LIMITED Current Company
BIOBEATS GROUP LTD united kingdom
MEDSUBONE LTD united kingdom
IPLATO LIMITED united kingdom
MEDOPAD LIMITED united kingdom

Charges

Charges

1 satisfied

Properties

Properties

1 leasehold 1 total
AddressTenurePrice PaidDate Added
Thirteenth Floor, Millbank Tower 21-24, Millbank, London (SW1P 4QP) CITY OF WESTMINSTER
Leasehold-7 May 2024
Thirteenth Floor, Millbank Tower 21-24, Millbank, London (SW1P 4QP)
Leasehold
Added 7 May 2024
District CITY OF WESTMINSTER

Documents

Company Filings

DateCategoryDescriptionDocument
10 Dec 2025Confirmation StatementConfirmation statement made on 2025-11-25 with updates
1 Dec 2025Persons With Significant ControlChange to Mr Danoosh Vahdat as a person with significant control on 2025-11-25
23 Oct 2025AccountsAnnual accounts made up to 2024-12-31
23 Jul 2025Persons With Significant ControlChange to Mr Danoosh Vahdat as a person with significant control on 2025-07-23
21 Jul 2025CapitalAllotment of shares (GBP 33,699.749) on 2025-04-25
10 Dec 2025 Confirmation Statement

Confirmation statement made on 2025-11-25 with updates

1 Dec 2025 Persons With Significant Control

Change to Mr Danoosh Vahdat as a person with significant control on 2025-11-25

23 Oct 2025 Accounts

Annual accounts made up to 2024-12-31

23 Jul 2025 Persons With Significant Control

Change to Mr Danoosh Vahdat as a person with significant control on 2025-07-23

21 Jul 2025 Capital

Allotment of shares (GBP 33,699.749) on 2025-04-25

Recent Activity

Latest Activity

Confirmation statement made on 2025-11-25 with updates

4 months ago on 10 Dec 2025

Change to Mr Danoosh Vahdat as a person with significant control on 2025-11-25

4 months ago on 1 Dec 2025

Annual accounts made up to 2024-12-31

5 months ago on 23 Oct 2025

Change to Mr Danoosh Vahdat as a person with significant control on 2025-07-23

8 months ago on 23 Jul 2025

Allotment of shares (GBP 33,699.749) on 2025-04-25

9 months ago on 21 Jul 2025